Transdermal Permeability of N-Acetyl-D-Glucosamine

REFERENCES

• Theodasakis Jason, Fox Barry, Adderly Beverly. The Arthritis Cure 1st. St. Martin's Press, New York 1997
   Google Scholar
• McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA. 2000; 283: 1469–1475
   PubMed Web of Science ®Google Scholar
• http://nccam.nih.gov/research/results/gait/qa.htm, Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT). National Center for Complementary and Alternative Medicine (NCCAM), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). September 1999
   Google Scholar
• Merrick J.M., Roseman S. Glucosamine metabolism. J. Biop. Chem. 1960; 5: 235–242
   Google Scholar
• Milewski S. Glucosamine-6-phophate synthase. Biochim. Biophys. Acta 2002; 1597: 173–192
   PubMed Web of Science ®Google Scholar
• Capomacchia A.C., Garner S.T., Beach W.J. NSAID/Glucosamine Mutual Prodrug and Uses Thereof. US Provisional Patent Application No. 60/560,128, 2004, Patent Application 235.00560201, Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions and methods, Capomacchia, AC; Garner, ST; Beach, WJ., ‘Glucosamine; filed April 7, 2005.
   Google Scholar
• Setnikar I., Giacchetti C., Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittel-Forschung 1986; 36(4)729–735
   PubMed Web of Science ®Google Scholar
• Aghazadeh-Habashi A., Sattari S., Pasutto F., Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J. Pharm. Pharm. Sci. 2002; 5(2)181–184
   PubMed Web of Science ®Google Scholar
• Setnikar I., Palumbo R., Canali S., Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittel-Forschung 1993; 43(10)1109–1113
   PubMed Web of Science ®Google Scholar
• Setnikar I., Rovati L C. Absorption, distribution, metabolism and excretion of glucosamine sulfate: A review. Arzneimittel-Forschung 2001; 51(9)699–725
   PubMed Web of Science ®Google Scholar
• Lamari F.N., Militsopoulou M., Mitropoulou T.N., Hjerpe A., Karamanos N.K. Analysis of glycosaminoglycan-derived disaccharides in biological samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans. Biomed. Chromatogr. 2002; 16: 95–102
   PubMedGoogle Scholar
• Optimal Settings for Pulsed Amperometric Detection of Carbohydrates Using the Dionex ED40 Electrochemical Detector, Technical Note 21, Dionex Corp., Sunnyvale, CA, USA.
   Google Scholar
• Clarke A.P., Jandik P., Rocklin R.D., Liu Y., Avdalovic N. An integrated amperometry waveform for the direct, sensitive detection of amino acids and amino sugars following anion exchange chromatography. Anal. Chem. 1999; 71: 2774–2781
   Web of Science ®Google Scholar
• Campo G.M., Campo S., Ferlazzo A.M., Vinci R., Calatroni A. Improved high-performance liquid chromatographic method to estimate amino sugars and its application to glycosaminoglycan determination in plasma and serum. J. Chromatogr. B 2001; 765: 151–160
   PubMed Web of Science ®Google Scholar
• LaCourse W.R. Pulsed Electrochemical Detection in High-Performance Liquid Chromatography. John Wiley & Sons Inc, New York 1997
   Google Scholar
• Itoh T., Xia J., Magavi R., Nishihata T., Rytting J.H. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: Comparison with human skin. Pharm. Res. 1990; 7: 1042–1047
   PubMed Web of Science ®Google Scholar
• Bach M., Lipppold B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 1998; 46: 1–13, Guidance for Indusry:
   PubMedGoogle Scholar
• Hadgraft J., Guy R.H. Feasibility assessment in topical and transdermal delivery: Mathematical models and in vitro studies. Transdermal Drug Delivery 2nd. Marcel Dekker, Inc, New York 2003; 1–23
   Google Scholar
• Bernacki R.J., Sharma M., Porter N.K., Rustum Y., Paul B., Korytnyk W. Biochemical characteristics, metabolism and antitumor activity of several acetylated hexosamines. J. Supramol. Struct. 1977; 7: 235–250
   PubMedGoogle Scholar
• Xudong Yuan, Capomacchia A.C. The binary eutectic of NSAIDs and two-phase liquid system for enhanced membrane permeation. Pharm. Dev. Technol. 2005; 1: 1–10
   Google Scholar
• Franz T.J., Lehman P.A., Kagy M.K. E.W. Smith, H.I. MaibachDimethyl sulfoxide. Percutaneous Enhancers, . CRC Press, Inc, Boca Raton, FL 1995; 112–127
   Google Scholar
• Barry B.W. Lipid-protein-patitioning theory of skin penetration enhancement. J. Control. Release 1991; 15: 237–248
   Web of Science ®Google Scholar
• Williams A.C., Barry B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 1992; 9: 305–353
   PubMed Web of Science ®Google Scholar
• Sinha V.R., Kaur M.P. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 2000; 26: 1131–1140
   PubMed Web of Science ®Google Scholar
• Berner B., Liu P. E.W. Smith, H.I. MaibachAlcohols, percutaneous penetration enhancers. Alcohols, . CRC Press, Boca Raton, FL 1995; 45–60
   Google Scholar
• Kurihara-Bergstrom T., Flynn G.L., Higuchi W.I. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: Dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin. J. Inv. Derma. 1987; 89: 274–280
   PubMedGoogle Scholar
• Magnusson B.M., Walters K.A., Roberts M.S. Veterinary drug delivery: Potential for skin penetration enhancement. Adv. Drug Del. Rev. 2001; 50: 205–227
   PubMed Web of Science ®Google Scholar
• Kanwischer M., Kim S.-Y., Bian S., Kwon A.E., Kim J.S., Kim D.-D. Evaluation of the physicochemical stability and skin permeation of glucosamine salts. Drug Dev. Ind. Pharm. 2005; 31(1)91–97
   PubMed Web of Science ®Google Scholar